Key references: Nausea and vomiting during pregnancy

  • Dormuth CR, Winquist B, Fisher A, Wu F, Reynier P, Suissa S, et al. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. JAMA Netw Open 2021;4(4):e215329. https://www.ncbi.nlm.nih.gov/pubmed/33890993
  • Huybrechts KF, Hernandez-Diaz S, Straub L, Gray KJ, Zhu Y, Patorno E, et al. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. JAMA 2018;320(23):2429-37. https://www.ncbi.nlm.nih.gov/pubmed/30561479
  • Lavecchia M, Chari R, Campbell S, Ross S. Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review. J Obstet Gynaecol Can 2018;40(7):910-8. https://www.ncbi.nlm.nih.gov/pubmed/29754832
  • Lowe SA, Bowyer L, Beech A, Robinson H, Armstrong G, Marnoch C, et al. Guideline for the management of nausea and vomiting in pregnancy and hyperemesis gravidarum. Sydney: Society of Obstetric Medicine of Australia and New Zealand; 2019. https://www.somanz.org/approval-of-written-guidelines-by-somanz/
  • Zambelli-Weiner A, Via C, Yuen M, Weiner DJ, Kirby RS. First trimester ondansetron exposure and risk of structural birth defects. Reprod Toxicol 2019;83:14-20. https://www.ncbi.nlm.nih.gov/pubmed/30385129